ID
33300
Beschrijving
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Trefwoorden
Versies (2)
- 05-11-18 05-11-18 -
- 04-12-18 04-12-18 -
Houder van rechten
GSK group of companies
Geüploaded op
4 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Pharmacogenetic Research Consent
- StudyEvent: ODM
Beschrijving
Sample Type
Alias
- UMLS CUI-1
- C2347029
Similar models
Pharmacogenetic Research Consent
- StudyEvent: ODM
C0035168 (UMLS CUI-2)
C1511481 (UMLS CUI-3)
C0200345 (UMLS CUI-4)
C0031325 (UMLS CUI [2,1])
C0035168 (UMLS CUI [2,2])
C0031325 (UMLS CUI [2,1])
C0035168 (UMLS CUI [2,2])
C1882120 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C1882120 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
C0031325 (UMLS CUI [2,1])
C0035168 (UMLS CUI [2,2])
Geen commentaren